Battling Breast Cancer
By targeting multiple HER-family receptors, small-molecule drugs could fill the therapeutic gaps left by Herceptin
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
August 7, 2006 Cover
Volume 84, Issue 32
By targeting multiple HER-family receptors, small-molecule drugs could fill the therapeutic gaps left by Herceptin
By targeting multiple HER-family receptors, small-molecule drugs could fill the therapeutic gaps left by Herceptin
Chemists' starting salaries are up a notch from 2004, but employment scene remains below par
Ghrelin vaccine permits male rats to gain less weight on usual diet
Beefing up signal of FRET kinase biosensors makes inexpensive high-throughput screening possible
The European Union explores ways to make it easier for cartel victims to recover damages
Congressionally legislated programs and projects circumvent traditional competitive grant process
New software and websites for the chemical enterprise